New Compounds to Fight Antibiotic Resistance in Mycobacterium abscessus
Author Information
Author(s): Sarrazin Morgane, Poncin Isabelle, Fourquet Patrick, Audebert Stéphane, Camoin Luc, Denis Yann, Santucci Pierre, Spilling Christopher D., Kremer Laurent, Le Moigne Vincent, Herrmann Jean-Louis, Cavalier Jean-François
Primary Institution: CNRS, LISM UMR7255, IMM-FR3479, Aix-Marseille Univ, Marseille, France
Hypothesis
Can Cyclipostins and Cyclophostin analogues counteract macrolide-induced resistance in Mycobacterium abscessus?
Conclusion
The study shows that Cyclipostins and Cyclophostin analogues can restore macrolide susceptibility in resistant strains of Mycobacterium abscessus.
Supporting Evidence
- The study identified Erm(41) as a target for CyC compounds.
- CyC compounds showed significant synergy with macrolides in restoring susceptibility.
- Results indicate that CyC can counteract macrolide resistance mechanisms.
Takeaway
Some new medicines can help fight a tough germ that makes people sick and doesn't respond to regular antibiotics.
Methodology
The study evaluated the in vitro activity of macrolides in combination with CyC compounds using checkerboard assays on both susceptible and resistant strains of Mycobacterium abscessus.
Limitations
The study primarily focuses on in vitro results, which may not fully translate to clinical outcomes.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website